Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Eisai (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
53%
Total
Publications
2.1K
Total Open
Publications
1.1K
Total
Citations
66K
Open Access
Percentage
53%
Total
Publications
2.1K
Total Open
Publications
1.1K
Total
Citations
66K
Breakdown
Publisher Open
26%
Both
21%
Other Platform Open
6%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 24%
234
Hybrid 49%
483
No Guarantees 27%
268
Other Platform Open
Domain 86%
475
Institution 19%
104
Other Internet 9%
51
Public 7%
36
Preprint 3%
16
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 478 |
Europe PMC | Domain | 201 |
DOI | Other Internet | 55 |
Figshare | Public | 46 |
University College London - UCL Discovery | Institution | 28 |
Semantic Scholar | Public | 20 |
bioRxiv | Preprint | 11 |
California Digital Library - eScholarship | Other Internet | 9 |
The University of Glasgow - Enlighten: Publications | Institution | 8 |
University of California - eScholarship University of California | Institution | 7 |